Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2000
04/27/2000DE19849073A1 Transgene encoding amyloid precursor protein or its fragment, used to produce transgenic nematodes used, e.g. to screen for agents for treating Alzheimer's disease
04/27/2000DE19849044A1 New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies
04/27/2000DE19848785A1 New thrombin inhibiting protein useful for diagnosis, treatment and prevention of thromboembolic diseases, is obtained from Dipetalogaster maximus
04/27/2000DE19848517A1 Controlling phytopathogenic fungi, useful particularly against Botrytis cinerea resistant to known fungicides, by treatment with peptide from Streptomyces tendae
04/27/2000DE19848515A1 Micro-titration plate recess has push-fit closure occupying space within reaction cavity, minimizing sample preparation and reaction time
04/27/2000DE19847142A1 Diagnosing borelliosis by detecting specific antibodies, using new Borellia antigens expressed preferentially during infection and also useful as immunogens in vaccines
04/27/2000DE19846001A1 Transgenic plant, especially potato, resistant to Phythophthora infestans, contains gene for hydroxycinnamic acid-coenzymeA: tyramine N-hydroxycinnamic acid transferase
04/27/2000DE19842863A1 Regulatorisches Protein aus humanen Keratinozyten Regulatory protein from human keratinocytes
04/27/2000DE19831429A1 Preparation and identification of polytopic peptide, useful e.g. therapeutically and for detecting antigens or antibodies, by linking fragments of a protein and testing for specific binding
04/27/2000CA2749553A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
04/27/2000CA2633345A1 A method of affinity separation and ligands for use therein
04/27/2000CA2364330A1 Secreted protein zsig49
04/27/2000CA2348156A1 Human proteins involved in endoplasmic reticulum protein degradation
04/27/2000CA2348153A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules
04/27/2000CA2348068A1 Adeno-associated vectors for expression of factor viii by target cells
04/27/2000CA2348053A1 Device for conducting biochemical and microbiological reactions
04/27/2000CA2347849A1 Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof
04/27/2000CA2347836A1 Proliferation and apoptosis related proteins
04/27/2000CA2347706A1 Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi
04/27/2000CA2347654A1 Human rna binding proteins
04/27/2000CA2347625A1 Genes and proteins predictive and therapeutic for renal disease and associated disorders
04/27/2000CA2347450A1 P53 binding areas
04/27/2000CA2347409A1 Human proteins stam2a and stam2b and cdnas encoding these molecules
04/27/2000CA2347369A1 Minimal promoters and uses thereof
04/27/2000CA2347214A1 Protein design automation for protein libraries
04/27/2000CA2347085A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
04/27/2000CA2347081A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
04/27/2000CA2347080A1 Tnfr related gene 12
04/27/2000CA2347079A1 Aminoacylase and its use in the production of d-aminoacids
04/27/2000CA2347062A1 Multiple domain glycoprotein hormones and methods of using
04/27/2000CA2347003A1 Modulation of gene expression by combination therapy
04/27/2000CA2346989A1 Dna-templated combinatorial library chemistry
04/27/2000CA2346942A1 Camel, an alternative translation product of the tumour antigen lage-1
04/27/2000CA2346937A1 Specific therapeutic interventions obtained by interference with redistribution and/or targeting
04/27/2000CA2346799A1 Delivery system for porcine somatotropin
04/27/2000CA2346798A1 Novel neuropilin/growth factor binding and uses thereof
04/27/2000CA2346717A1 Detection and quantification of vancomycin in biological fluids
04/27/2000CA2346500A1 Methods and reagents for isolating biologically active peptides
04/27/2000CA2346152A1 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors
04/27/2000CA2345938A1 Polymorphism in a tgf-beta gene correlated to osteoporosis
04/27/2000CA2345382A1 Inhibitors of platelet activation and recruitment
04/27/2000CA2344625A1 Methods for manipulating complex nucleic acid populations using peptide-labeled oligonucleotides
04/27/2000CA2344605A1 G-protein coupled receptors
04/27/2000CA2343974A1 Materials and methods involving conditional aggregation domains
04/27/2000CA2343917A1 Materials and methods involving conditional retention domains
04/27/2000CA2343094A1 Interferon-beta fusion proteins and uses
04/27/2000CA2315104A1 Functionalized pyrimidine derivatives
04/26/2000EP0995804A2 Nucleic acid analysis using complete N-mer arrays
04/26/2000EP0995802A2 Method for the delivery of nucleic acids to cells in vitro or ex vivo
04/26/2000EP0995801A1 Process for increasing the stability of enzymes and stabilized enzymes
04/26/2000EP0995800A1 Probes for the diagnosis of infections caused by bacteroides fragilis
04/26/2000EP0995799A2 Coccidiosis vaccines
04/26/2000EP0995798A1 Transcription factor of MHC class II genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
04/26/2000EP0995797A1 Methods for detecting and isolating nuclear transport proteins
04/26/2000EP0995445A2 Ligand-mediated immunofunctional hormone binding protein assay method
04/26/2000EP0995271A1 Biological data
04/26/2000EP0995120A1 Protein elongation factor 2 as a target for antifungal and antiparasitic agents
04/26/2000EP0995118A1 Chaperone fragments
04/26/2000EP0994966A1 Member of the tnf family useful for treatment and diagnosis of disease
04/26/2000EP0994965A2 Taqman?tm -pcr for the detection of pathogenic e. coli strains
04/26/2000EP0994964A1 Detection of nuceic acids by multiple sequential invasive cleavages
04/26/2000EP0994963A1 Non-invasive prenatal diagnosis
04/26/2000EP0994962A1 An indexed library of cells containing genomic modifications and methods of making and utilizing the same
04/26/2000EP0994960A1 Methods for the detection of multiple single nucleotide polymorphisms in a single reaction
04/26/2000EP0994959A1 Polymer-modified viruses
04/26/2000EP0994958A2 Selective regulation of adenovirus production
04/26/2000EP0994957A1 Transgenic plants using the tdc gene for crop improvement
04/26/2000EP0994956A1 Male tissue-preferred regulatory region and method of using same
04/26/2000EP0994955A1 Increased production of secreted proteins by recombinant yeast cells
04/26/2000EP0994954A1 T7 promoter-based expression system
04/26/2000EP0994953A1 Expression system for production of therapeutic proteins
04/26/2000EP0994952A1 Plant atp-phosphoribosyl transferase and dna coding therefor
04/26/2000EP0994951A1 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin b and related compounds
04/26/2000EP0994950A2 Dna sequences, expression of said dna sequences, thermopile laccases coded by said dna sequences and the use thereof
04/26/2000EP0994949A1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
04/26/2000EP0994948A1 TGF$g(b) RII RECEPTOR NUCLEIC SEQUENCE, CODED PEPTIDE, AND USES
04/26/2000EP0994947A1 Mu-1, member of the cytokine receptor family
04/26/2000EP0994946A1 Coding sequence haplotypes of the human brca2 gene
04/26/2000EP0994945A2 Smad-interacting polypeptides and their use
04/26/2000EP0994942A1 Improved promoters for enhancing plant productivity
04/26/2000EP0994904A2 AMINO ACID SEQUENCES FOR THERAPEUTICAL AND PROPHYLACTIC APPLICATIONS TO DISEASES DUE TO $i(CLOSTRIDIUM DIFFICILE) TOXINS
04/26/2000EP0994903A1 Methods and compositions for galactosylated glycoproteins
04/26/2000EP0994900A1 Semaphorin receptors
04/26/2000EP0994899A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM
04/26/2000EP0994891A1 Eukaryotic and retroviral antisense initiator elements
04/26/2000EP0994728A1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof
04/26/2000EP0994726A2 Compositions suitable for delivery of genes to epithelial cells
04/26/2000EP0994724A1 Methods and compositions for impairing multiplication of hiv-1
04/26/2000EP0972085A4 Sensors for electrically sensing binding events for supported molecular receptors
04/26/2000EP0925304B1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism
04/26/2000EP0789716B1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof
04/26/2000EP0684992B1 Method for obtaining an increased production of a producing celline by using a fusion protocol
04/26/2000EP0656945B1 Stress protein epitopes
04/26/2000EP0656013B1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus
04/26/2000EP0652947B1 Alkaline protease and process for its production
04/26/2000CN1251617A Gene sequencer and method
04/26/2000CN1251616A Large scale genotyping of diseases and diagnostic test for spinocerebellar ataxia type 6
04/26/2000CN1251615A Assay for measurement of DNA synthesis rates
04/26/2000CN1251614A New EIA test using non-dentured HIV antigen for early detection of HIV infection
04/26/2000CN1251613A Alpha-amylase mutant